T. Srivastava, R.E. Garola, H.K. Singh  Kidney International 

Slides:



Advertisements
Similar presentations
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and.
Advertisements

Volume 70, Issue 3, Pages (August 2006)
Renal vitamin D receptor expression and vitamin D renoprotection
Regulation of mesangial cell proliferation
Volume 63, Issue 1, Pages (January 2003)
Mechanical stress reduces podocyte proliferation in vitro
Volume 63, Issue 1, Pages (January 2003)
Volume 86, Issue 6, Pages (December 2014)
Volume 72, Issue 1, Pages (July 2007)
Infantile nephropathic cystinosis
Mechanical stretch induces podocyte hypertrophy in vitro1
Molecular mechanisms of diabetic renal hypertrophy
Volume 71, Issue 8, Pages (April 2007)
Kidney International in 2007: Celebrating new features
Volume 72, Issue 5, Pages (September 2007)
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali 
The role of protein kinase C activation in diabetic nephropathy
Volume 71, Issue 11, Pages (June 2007)
Cell cycle regulatory proteins in glomerular disease
Volume 56, Issue 5, Pages (November 1999)
Volume 71, Issue 6, Pages (March 2007)
Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon 
Volume 70, Issue 12, Pages (December 2006)
Analgesic nephropathy
Blood pressure targets in hemodialysis patients
Synaptopodin expression in idiopathic nephrotic syndrome of childhood
F. Verrey, P. Fakitsas, G. Adam, O. Staub  Kidney International 
Fructose intake as a risk factor for kidney stone disease
Volume 72, Issue 3, Pages (August 2007)
Structure, not just function
The third World Kidney Day: Looking back and thinking forward
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Crossed fused ectopia of the kidneys
Volume 56, Issue 4, Pages (October 1999)
Volume 69, Issue 11, Pages (June 2006)
Volume 69, Issue 8, Pages (April 2006)
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Volume 71, Issue 4, Pages (February 2007)
Volume 73, Issue 3, Pages (February 2008)
Volume 69, Issue 11, Pages (June 2006)
Regulation of the G1/S transition phase in mesangial cells by E2F1
Immunity unmasks APOL1 in collapsing glomerulopathy
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Volume 72, Issue 3, Pages (August 2007)
Direct effects of dexamethasone on human podocytes
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease  B. Sis, A. Tasanarong, F. Khoshjou,
Is it the low-protein diet or simply the salt restriction?
Volume 70, Issue 3, Pages (August 2006)
Is complement a target for therapy in renal disease?
Urinalysis in Western culture: A brief history
Volume 70, Issue 3, Pages (August 2006)
Naoki Ikegaya, Akira Hishida, Tatsuo Yamamoto  Kidney International 
A 39-year-old pregnant woman with polyuria and hypomagnesemia
A nest in renal fibrosis?
Volume 71, Issue 9, Pages (May 2007)
Volume 70, Issue 5, Pages (September 2006)
Volume 58, Issue 1, Pages (July 2000)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 69, Issue 8, Pages (April 2006)
D. Cosgrove, R. Kalluri, J.-H. Miner, Y. Segal, D.-B. Borza 
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 72, Issue 4, Pages (August 2007)
Volume 56, Issue 4, Pages (October 1999)
Presentation transcript:

Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children  T. Srivastava, R.E. Garola, H.K. Singh  Kidney International  Volume 70, Issue 3, Pages 529-535 (August 2006) DOI: 10.1038/sj.ki.5001577 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 The photomicrograph shows the staining of p27, p21, p57, and cyclins D and A in podocytes of normal and children with MCD, classic FSGS, and CGN in kidney tissue. The podocyte is identified by WT-1 staining (stained red with Vector red) and the cell-cycle regulatory protein is stained brown-black with diaminobenzidine with 3% cobalt. Only podocytes that showed homogeneous staining for cell-cycle regulatory proteins above the background were accepted as positive staining. The staining for p27 decreased in order from normal to MCD to CGN to FSGS. p21 staining was markedly decreased in children with MCD, CGN, or FSGS compared to normal. p57 staining remained unchanged between normal, MCD, FSGS, and CGN. Cyclin D expression was increased in CGN and similar between normal, MCD, and FSGS. Cyclin A expression was only observed in CGN and absent in normal, MCD, or FSGS. Kidney International 2006 70, 529-535DOI: (10.1038/sj.ki.5001577) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Schematic diagram of cell-cycle phases, checkpoints, and restriction point (R) in a eukaryotic cell showing major cyclin and cyclin kinase inhibitors (CKI). The cell-cycle arrest can occur at G1/S or G2/M checkpoint. The podocyte is a terminally differentiated cell that normally expresses low level of cyclin D and CKIs’ p27, p21, and p57. The podocyte in MCD and FSGS remain trapped in G1/S phase as suggested by a decrease in CKIs’ p27 and p21, but not p57, and no increase in cyclins D or A. On the other hand, podocyte in CGN shows a decrease in CKIs’ p27 and p21, but not p57, and increase in cyclins D and A. Kidney International 2006 70, 529-535DOI: (10.1038/sj.ki.5001577) Copyright © 2006 International Society of Nephrology Terms and Conditions